Abstract
Within the field of molecular cardiac electrophysiology, the previous two decades of research have elucidated the fundamental genetic substrates underlying many arrhythmogenic disorders associated with sudden cardiac death including long QT syndrome (LQTS), Andersen-Tawil syndrome, Timothy syndrome, short QT syndrome (SQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), Brugada Syndrome (BrS), familial AV block, early repolarization syndrome, and atrial fibrillation. In addition, the molecular underpinnings for structural cardiomyopathies vulnerable to sudden arrhythmic death: dilated cardiomyopathy, hypertrophic cardiomyopathy, left ventricular noncompaction syndrome, and arrhythmogenic right ventricular cardiomyopathy, are understood now in greater detail. Gene testing for several of these heritable channelopathies and cardiomyopathies are currently available through specialized clinical and/or research based laboratories.
The purpose of this chapter is to equip the reader with a basic understanding of molecular genetics and genetic testing in the setting of cardiac electrophysiologic disorders. First, the chapter will present a primer on fundamental molecular genetics including the organization of the human genome, transfer of genetic information, different modes of inheritance, and types of mutations in human genetic disease. Next, techniques utilized in genetic testing will be illustrated. And finally, this chapter will address the important issues of genetic testing, including clinical versus research based testing, benefits of genetic testing, limitations to genetic testing, interpretation of the genetic test, role of genetic counselors, and ethical, legal and societal implications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baird PA, Anderson TW, Newcombe HB, Lowry RB. Genetic disorders in children and young adults: a population study. Am J Hum Genet. 1988;42(5):677–93.
Strachan T, Read AP. Human molecular genetics 2. New York: Wiley-Liss; 1999.
Nussbaum RL, McInnes RR, Willard HF. Thompson & Thompson genetics in medicine. 6th ed. Philadelphia: WB Saunders Co; 2001. p. 51–94.
Tester DJ, Ackerman MJ. Genomics and principles of clinical genetics. In: Saksena S, editor. Electrophysiological disorders of the heart. Philadelphia: Elsevier/Saunders; 2012. p. 73–84.
Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2005;2(5):507–17.
Tester DJ, Ackerman MJ. The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol. 2006;21(3):166–72.
Tester DJ, Will ML, Ackerman MJ. Chapter 13: Mutation detection in congenital long QT syndrome. In: Wang QK, Wang QK, editors. Cardiovascular disease: methods and protocols, Genetics, vol. 1. Totowa: Humana Press Inc; 2006. p. 181–207.
Tester DJ, Cronk LB, Carr JL, et al. Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false negative results. Heart Rhythm. 2006;3:815–21.
Ning L, Moss A, Zareba W, et al. Denaturing high-performance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome. Genet Test. 2003;7(3):249–53.
Spiegelman JI, Mindrinos MN, Oefner PJ. High-accuracy DNA sequence variation screening by DHPLC. Biotechniques. 2000;29(5):1084–92.
Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003;78(12):1479–87.
Ackerman MJ, Splawski I, Makielski JC. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing [see comment]. Heart Rhythm. 2004;1(5):600–7.
Mardis ER. Next-generation DNA, sequencing methods. Annu Rev Genomics Hum Genet. 2008;9:387–402.
Porreca GJ, Zhang K, Li JB. Multiplex amplification of large sets of human exons [see comment]. Nat Methods. 2007;4(11):931–6.
Eddy C-A, MacCormick JM, Chung S-K, et al. Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome [see comment]. Heart Rhythm. 2008;5(9):1275–81.
Koopmann TT, Alders M, Jongbloed RJ, et al. Long QT syndrome caused by a large duplication in the KCNH2 (HERG) gene undetectable by current polymerase chain reaction-based exon-scanning methodologies [see comment]. Heart Rhythm. 2006;3(1):52–5.
Tester DJ, Ackerman MJ. Novel gene and mutation discovery in congenital long QT syndrome: let’s keep looking where the street lamp standeth [comment]. Heart Rhythm. 2008;5(9):1282–4.
Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80(5):795–803.
Wang Q, Shen J, Li Z, et al. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet. 1995;4(9):1603–7.
Napolitano C, Bloise R, Priori SG. Gene-specific therapy for inherited arrhythmogenic diseases. Pharmacol Ther. 2006;110(1):1–13.
Tester DJ, Ackerman MJ. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice. Circulation. 2011;123(9):1021–37.
Constantin CM, Faucett A, Lubin IM. A primer on genetic testing. J Midwifery Womens Health. 2005;50(3):197–204.
Ehrmeyer SS, Laessig RH. Regulatory compliance for point-of-care testing: 2009 United States perspective. Clin Lab Med. 2009;29(3):463–78.
Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009;54(3):201–11.
Shimizu W. Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. Circ J. 2008;72(12):1926–36.
Ruan Y, Liu N, Napolitano C, Priori SG. Therapeutic strategies for long-QT syndrome: does the molecular substrate matter? Circ Arrhythm Electrophysiol. 2008;1(4):290–7.
Tester DJ, Ackerman MJ. Genetic testing for cardiac channelopathies: ten questions regarding clinical considerations for heart rhythm allied professionals. Heart Rhythm. 2005;2(6):675–7.
Priori SG, Napolitano C. Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies. Circulation. 2006;113(8):1130–5.
Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8(8):1308–39.
Gollob MH, Blier L, Brugada R, et al. Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol. 2011;27(2):232–45.
Charron P. Clinical genetics in cardiology. Heart. 2006;92(8):1172–6.
Hershberger RE, Cowan J, Morales A, Siegfried JD. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail. 2009;2(3):253–61.
Thomas SM. Society and ethics – the genetics of disease. Curr Opin Genet Dev. 2004;14(3):287–91.
Lea DH, Williams J, Donahue MP. Ethical issues in genetic testing. J Midwifery Womens Health. 2005;50(3):234–40.
Abiola S. Recent developments in health law. The Genetic Information Nondiscrimination Act of 2008: “First major Civil Rights bill of the century” bars misuse of genetic test results. J Law Med Ethics. 2008;36(4):856–60.
Van Riper M. Genetic testing and the family. J Midwifery Womens Health. 2005;50(3):227–33.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Tester, D.J., Ackerman, M.J. (2013). Genetic Testing. In: Gussak, I., Antzelevitch, C. (eds) Electrical Diseases of the Heart. Springer, London. https://doi.org/10.1007/978-1-4471-4978-1_20
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4978-1_20
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4977-4
Online ISBN: 978-1-4471-4978-1
eBook Packages: MedicineMedicine (R0)